RFK Jr. overhauls U.S. vaccine policy, sparking debate over safety and trust
By willowt // 2026-06-19
Copy
 
  • The Trump administration has revised U.S. childhood vaccine recommendations, reducing broad endorsements for vaccines like flu, hepatitis A and rotavirus.
  • HHS Secretary Robert F. Kennedy Jr. dismantled the CDC’s Advisory Committee on Immunization Practices (ACIP) months ago, citing conflicts of interest and industry influence.
  • Critics argue the changes endanger public health and misrepresent international vaccine schedules, while Kennedy claims they aim to restore trust through transparency.
  • A federal judge recently blocked ACIP’s new members and halted vaccine policy revisions, citing flawed processes and inadequate public input.
  • The overhaul includes a push for “shared clinical decision-making” in vaccine administration and renewed scrutiny of cumulative safety studies.
On June 17, the U.S. Department of Health and Human Services (HHS) announced sweeping changes to childhood vaccine recommendations under Secretary Robert F. Kennedy Jr., a vocal vaccine skeptic. The revisions, which removed broad endorsements for vaccines like influenza and hepatitis A, reflect Kennedy’s agenda to prioritize “shared clinical decision-making” and address perceived conflicts of interest in federal health agencies. The dismantling of the CDC’s Advisory Committee on Immunization Practices (ACIP) in February 2026 marked a pivotal step in this overhaul, aiming to reshape vaccine policy through increased transparency and parental input. The debate has intensified as medical experts warn of potential public health risks, while Kennedy’s allies argue the changes align the U.S. with international norms and restore public confidence in immunization programs.

Dismantling ACIP: A central move

Kennedy’s decision to disband the 17-member ACIP, an independent panel of medical and public health experts, has drawn sharp criticism. The committee, which traditionally advises the CDC on vaccine use, was replaced with a new slate of members, including several vaccine skeptics. A federal judge recently blocked these appointments, citing procedural flaws and insufficient public consultation. Kennedy defended the move, asserting that the previous panel lacked independence from pharmaceutical interests and failed to address cumulative vaccine safety. The judge’s ruling has stalled new vaccine recommendations and delayed updates to guidelines ahead of the 2026 flu season, creating uncertainty for healthcare providers and families.

Legal and scientific challenges

The revised vaccine schedule has faced legal and scientific scrutiny. A lawsuit seeks to reclassify most CDC-recommended vaccines to “Category B: Shared Clinical Decision-Making,” requiring individualized risk assessments by doctors and parents. Plaintiffs argue that the CDC has not proven the cumulative safety of administering over 70 vaccines during childhood. Meanwhile, medical organizations like the American Academy of Pediatrics (AAP) condemn the changes as “dangerous and unnecessary,” warning that reducing broad vaccine recommendations could lead to preventable disease outbreaks. Critics also highlight discrepancies in international comparisons, noting that countries like Denmark have different healthcare systems and disease burdens, making direct comparisons misleading.

A longstanding agenda

Kennedy’s vaccine skepticism has deep roots. Since the 1990s, he has advocated for stricter oversight of vaccine safety and co-founded the Children’s Health Defense, an anti-vaccine organization. His tenure at HHS has revived a 1990s-era Task Force on Safer Childhood Vaccines and intensified scrutiny of vaccine ingredients like thimerosal, a mercury-based preservative. The dismantling of ACIP echoes past efforts to challenge vaccine authority, such as his push to revise CDC statements on autism and vaccines. Despite assurances during his confirmation that he would not “discourage people from taking vaccines,” Kennedy’s policies reflect a broader anti-vaccine agenda that has gained traction among certain political and advocacy groups.

A divisive policy with lasting implications

As the HHS navigates legal battles and scientific pushback, the long-term impact of Kennedy’s vaccine agenda remains uncertain. The shift to shared decision-making and reduced broad vaccine recommendations has polarized public health experts and policymakers. While Kennedy’s allies frame the changes as a necessary step to rebuild trust in an industry they claim is compromised by corporate interests, critics warn of eroding herd immunity and rising preventable disease risks. The ongoing legal challenges and stalled ACIP appointments underscore the contentious nature of this overhaul, which could reshape U.S. vaccine policy for years to come Sources for this article include: ChildrensHealthDefense.org WashingtonPost.com ProtectOurCare.org
Copy